WPW
NVS icon

Winthrop Partners - WNY’s Novartis NVS Stock Holding History

Winthrop Partners - WNY’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$121K Hold
1,392
– – 0.08% 139
2019
Q2 		$127K Sell
1,392
-161
-10% -$13.6K 0.1% 118
2019
Q1 		$133K Buy
1,553
+176
+13% +$14.1K 0.1% 114
2018
Q4 		$106K Hold
1,377
– – 0.1% 120
2018
Q3 		$106K Hold
1,377
– – 0.09% 137
2018
Q2 		$93.2K Hold
1,377
– – 0.08% 146
2018
Q1 		$100K Buy
+1,377
New +$105K 0.08% 160

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Winthrop Partners - WNY's NVS Position: Q3 2019 in Review

Winthrop Partners - WNY held its Novartis (NVS) position steady in Q3 2019 at 1,392 shares worth $121K. The position accounts for 0.08% of the portfolio, ranked #139.

Winthrop Partners - WNY first reported a position in NVS in Q1 2018 and has held it in 7 quarters since. The position peaked at $133K in Q1 2019. 1,090 funds tracked by Wall St. Rank hold NVS as of Q3 2019.

  • Winthrop Partners - WNY held 1,392 shares of Novartis worth $121K as of Q3 2019.
  • Winthrop Partners - WNY left its Novartis share count unchanged in Q3 2019.
  • Novartis made up 0.08% of Winthrop Partners - WNY's portfolio in Q3 2019, its #139 holding.
  • Winthrop Partners - WNY first reported a position in Novartis in Q1 2018 and has held it in 7 quarters since.
  • Winthrop Partners - WNY's Novartis position peaked at $133K in Q1 2019.
  • 1,090 funds tracked by Wall St. Rank held Novartis as of Q3 2019.

Based on Winthrop Partners - WNY's 13F filing for Q3 2019, filed 28 Oct 2019.